Combined PVI and LAAC study
Part of Heart & circulation clinical trials.
This study is testing if a procedure that combines two treatments—pulmonary vein isolation for atrial fibrillation and left atrial appendage closure to lower stroke risk—can be done safely together. It's for people who need both treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You need to be a candidate for a procedure called pulmonary vein isolation (PVI), which treats irregular heart rhythms.
- You also need to be a candidate for a procedure called left atrial appendage closure (LAAC), which helps prevent strokes.
- If you are not eligible for either procedure, you cannot join this trial.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests doing a single procedure that treats atrial fibrillation (irregular heartbeat) and also reduces the risk of stroke by sealing off a small part of the heart. This might help people who need both treatments, so they can have one procedure instead of two.
This trial compares different techniques for a second heart ablation procedure in people with atrial fibrillation (AFib) who have already had one ablation. It aims to find the best approach to stop AFib from coming back.
This trial compares two catheter ablation techniques for people with persistent atrial fibrillation (a type of irregular heartbeat that doesn't go away on its own). It will test whether a more extensive ablation (burning more heart tissue) works better than the standard procedure of isolating the pulmonary veins (the veins that bring blood from the lungs to the heart). If you have this condition and have had at least one episode in the past year, this study might help you find a more effective treatment.
This study compares two extra ablation procedures done along with standard pulmonary vein isolation in people with persistent atrial fibrillation. Both aim to stop abnormal electrical signals that drive atrial fibrillation, and the study will see which approach is safer and more effective.
This study tests a new type of ablation (pulsed field ablation) for people with atrial fibrillation who haven't gotten enough relief from medication alone. It aims to see if isolating the superior vena cava along with the pulmonary veins is safe and effective.
This study compares two ways of doing a repeat heart procedure for atrial fibrillation (an irregular heartbeat). It tests whether adding extra ablation (using energy to destroy small areas of heart tissue) on the back wall of the heart's upper left chamber helps prevent the irregular heartbeat from coming back.
Hear when a new Atrial Fibrillation (AF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.